Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

25 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Nonclassical Monocytes Are Prone to Migrate Into Tumor in Diffuse Large B-Cell Lymphoma.
Le Gallou S, Lhomme F, Irish JM, Mingam A, Pangault C, Monvoisin C, Ferrant J, Azzaoui I, Rossille D, Bouabdallah K, Damaj G, Cartron G, Godmer P, Le Gouill S, Casasnovas RO, Molina TJ, Houot R, Lamy T, Tarte K, Fest T, Roussel M. Le Gallou S, et al. Front Immunol. 2021 Dec 16;12:755623. doi: 10.3389/fimmu.2021.755623. eCollection 2021. Front Immunol. 2021. PMID: 34975843 Free PMC article.
Characterization of a transitional preplasmablast population in the process of human B cell to plasma cell differentiation.
Jourdan M, Caraux A, Caron G, Robert N, Fiol G, Rème T, Bolloré K, Vendrell JP, Le Gallou S, Mourcin F, De Vos J, Kassambara A, Duperray C, Hose D, Fest T, Tarte K, Klein B. Jourdan M, et al. Among authors: le gallou s. J Immunol. 2011 Oct 15;187(8):3931-41. doi: 10.4049/jimmunol.1101230. Epub 2011 Sep 14. J Immunol. 2011. PMID: 21918187
Preclinical Development of a Bispecific Antibody that Safely and Effectively Targets CD19 and CD47 for the Treatment of B-Cell Lymphoma and Leukemia.
Buatois V, Johnson Z, Salgado-Pires S, Papaioannou A, Hatterer E, Chauchet X, Richard F, Barba L, Daubeuf B, Cons L, Broyer L, D'Asaro M, Matthes T, LeGallou S, Fest T, Tarte K, Clarke Hinojosa RK, Genescà Ferrer E, Ribera JM, Dey A, Bailey K, Fielding AK, Eissenberg L, Ritchey J, Rettig M, DiPersio JF, Kosco-Vilbois MH, Masternak K, Fischer N, Shang L, Ferlin WG. Buatois V, et al. Mol Cancer Ther. 2018 Aug;17(8):1739-1751. doi: 10.1158/1535-7163.MCT-17-1095. Epub 2018 May 9. Mol Cancer Ther. 2018. PMID: 29743205 Free PMC article.
Early-stage myeloid-derived suppressor cell count: Basophil exclusion matters.
Uhel F, Azzaoui I, Le Gallou S, Fest T, Tarte K, Roussel M. Uhel F, et al. Among authors: le gallou s. J Allergy Clin Immunol. 2019 Oct;144(4):1125-1127. doi: 10.1016/j.jaci.2019.06.027. Epub 2019 Jul 3. J Allergy Clin Immunol. 2019. PMID: 31279012 Free article. No abstract available.
SARS-CoV-2-Induced ARDS Associates with MDSC Expansion, Lymphocyte Dysfunction, and Arginine Shortage.
Reizine F, Lesouhaitier M, Gregoire M, Pinceaux K, Gacouin A, Maamar A, Painvin B, Camus C, Le Tulzo Y, Tattevin P, Revest M, Le Bot A, Ballerie A, Cador-Rousseau B, Lederlin M, Lebouvier T, Launey Y, Latour M, Verdy C, Rossille D, Le Gallou S, Dulong J, Moreau C, Bendavid C, Roussel M, Cogne M, Tarte K, Tadié JM. Reizine F, et al. Among authors: le gallou s. J Clin Immunol. 2021 Apr;41(3):515-525. doi: 10.1007/s10875-020-00920-5. Epub 2021 Jan 2. J Clin Immunol. 2021. PMID: 33387156 Free PMC article.
Linking the KIR phenotype with STAT3 and TET2 mutations to identify chronic lymphoproliferative disorders of NK cells.
Pastoret C, Desmots F, Drillet G, Le Gallou S, Boulland ML, Thannberger A, Doncker AV, Salaun V, Damaj GL, Veyrat-Masson R, Tournilhac O, Moignet A, Pangault C, Roussel M, Fest T, Lamy T. Pastoret C, et al. Among authors: le gallou s. Blood. 2021 Jun 10;137(23):3237-3250. doi: 10.1182/blood.2020006721. Blood. 2021. PMID: 33512451 Free PMC article.
25 results